Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H12O6 |
| Molecular Weight | 300.2629 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C2=C(O)C(=O)C3=C(O2)C=C(O)C=C3O
InChI
InChIKey=SQFSKOYWJBQGKQ-UHFFFAOYSA-N
InChI=1S/C16H12O6/c1-21-10-4-2-8(3-5-10)16-15(20)14(19)13-11(18)6-9(17)7-12(13)22-16/h2-7,17-18,20H,1H3
| Molecular Formula | C16H12O6 |
| Molecular Weight | 300.2629 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Kaempferide (3,5,7-trihydroxy-4′-methoxyflavone,
Kae) is a naturally occurring flavonoid that is
isolated from the roots of Alpinia officinarum (lesser galangal). Like other flavonoids, Kae also has a very good
antioxidant properties and Kae can effectively reduce 1,1-
diphenyl-2-picrylhydrazyl (DPPH). Studies have shown
that Kae has anticancer and antihypertension effects. Kaempferide protects against myocardial Ischemia/reperfusion Injury through activation of the PI3K/Akt/GSK-3β pathway. Kaempferide inhibited potent antioxidant activity. Kaempferide is one of the candidates for active compound in propolis. Kaempferide, the most active among the four flavonoids isolated and characterized from Chromolaena odorata, induces apoptosis in cervical cancer cells while being pharmacologically safe.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P0AGJ9 Gene ID: 948855.0 Gene Symbol: tyrS Target Organism: Escherichia coli (strain K12) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27487455 |
|||
Target ID: CHEMBL3551 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25580686 |
|||
Target ID: WP408 |
|||
Target ID: CHEMBL4261 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21865046 |
|||
Target ID: CHEMBL5346 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19615910 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy. | 2012-06 |
|
| Reversing β-lactam antibiotic resistance of Staphylococcus aureus with galangin from Alpinia officinarum Hance and synergism with ceftazidime. | 2010-12-15 |
|
| Inhibition of in vitro growth and arrest in the G0/G1 phase of HCT8 line human colon cancer cells by kaempferide triglycoside from Dianthus caryophyllus. | 2010-09 |
|
| Effects of single and multiple flavonoids on BCRP-mediated accumulation, cytotoxicity and transport of mitoxantrone in vitro. | 2010-07 |
|
| Interaction of flavonoids, the naturally occurring antioxidants with different media: a UV-visible spectroscopic study. | 2010-04 |
|
| Inhibitory activity of Brazilian green propolis components and their derivatives on the release of cys-leukotrienes. | 2010-01-01 |
|
| Studies on the homolytic and heterolytic cleavage of kaempferol and kaempferide glycosides using electrospray ionization tandem mass spectrometry. | 2010-01 |
|
| Oleuropein in olive and its pharmacological effects. | 2009-12-20 |
|
| 6-Hydroxy-methyl-4-meth-oxy-2H-pyran-2-one (Opuntiol). | 2009-12-19 |
|
| Methylation of dietary flavones increases their metabolic stability and chemopreventive effects. | 2009-11-18 |
|
| Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells. | 2009-08-15 |
|
| From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine. | 2009-07-22 |
|
| Antihypertensive effects of flavonoids isolated from brazilian green propolis in spontaneously hypertensive rats. | 2009-07 |
|
| Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. | 2009-06-16 |
|
| A new chalcone glycoside from Rhamnus nipalensis. | 2008-12 |
|
| Metabolic modifications of birch leaf phenolics by an herbivorous insect: detoxification of flavonoid aglycones via glycosylation. | 2008-11-13 |
|
| [Studies on chemical constituents of Salacia prinoides]. | 2008-09 |
|
| Brazilian propolis: correlation between chemical composition and antimicrobial activity. | 2008-09 |
|
| Chemical composition and botanical origin of red propolis, a new type of brazilian propolis. | 2008-09 |
|
| Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism. | 2008 |
|
| Effects of propolis crude hydroalcoholic extract on chromosomal aberrations induced by doxorubicin in rats. | 2007-12 |
|
| Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones. | 2007-11 |
|
| [Studies on flavonoids of Oxytropis falcata]. | 2007-02 |
|
| Phenolics of Moringa oleifera leaves. | 2007-01 |
|
| Flavonoids from Echinops echinatus. | 2006-07-26 |
|
| In vitro antimalarial activity of flavonoid derivatives dehydrosilybin and 8-(1;1)-DMA-kaempferide. | 2006-01 |
|
| ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. | 2005-10-04 |
|
| Effect of Brazilian green propolis on the production of reactive oxygen species by stimulated neutrophils. | 2004-09 |
|
| Flavonol glycosides of Warburgia ugandensis leaves. | 2003-10 |
|
| Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9. | 2002-02 |
|
| Phenolic compounds of propolis from Central Chilean matorral. | 2001-05-24 |
|
| Kaempferide triglycoside: a possible factor of resistance of carnation (Dianthus caryophyllus) to Fusarium oxysporum f. sp. dianthi. | 2001-04 |
|
| Inhibitory activity of flavonoids and tannins against HIV-1 protease. | 2000-09 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28928604
Rats were randomly divided into
7 groups: (1) sham group, rats underwent sham surgery;
(2) I/R group, rats were subjected to a 30 min LAD coronary
artery ligation followed by a 2 h reperfusion; (3) L-Kae (Kaempferide) + I/R
group, rats were injected with a low dose of Kae (L-Kae;
0.1 mg/kg body weight) 30 min prior to I/R, then subjected
to a 30 min LAD coronary artery ligation followed by a 2 h
reperfusion; (4) M-Kae + I/R group, rats were injected with
a moderate dose of Kae (M-Kae; 0.3 mg/kg body weight)
30 min prior to I/R, then subjected to a 30 min LAD coronary
artery ligation followed by a 2 h reperfusion; (5) H-Kae + I/R
group, rats were injected with a high dose of Kae (H-Kae;
1 mg/kg body weight) 30 min prior to I/R, then subjected to
a 30 min LAD coronary artery ligation followed by a 2 h
reperfusion;
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19615910
Kaempferide inhibited melanogenesis (81.2% inhibition) in theophylline-stimulated mouse B16-4A5 cells at 30 uM after 72 hrs
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:38:30 GMT 2025
by
admin
on
Mon Mar 31 19:38:30 GMT 2025
|
| Record UNII |
508XL61MPD
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
58925
Created by
admin on Mon Mar 31 19:38:30 GMT 2025 , Edited by admin on Mon Mar 31 19:38:30 GMT 2025
|
PRIMARY | |||
|
491-54-3
Created by
admin on Mon Mar 31 19:38:30 GMT 2025 , Edited by admin on Mon Mar 31 19:38:30 GMT 2025
|
PRIMARY | |||
|
207-738-4
Created by
admin on Mon Mar 31 19:38:30 GMT 2025 , Edited by admin on Mon Mar 31 19:38:30 GMT 2025
|
PRIMARY | |||
|
6099
Created by
admin on Mon Mar 31 19:38:30 GMT 2025 , Edited by admin on Mon Mar 31 19:38:30 GMT 2025
|
PRIMARY | |||
|
KAEMPFERIDE
Created by
admin on Mon Mar 31 19:38:30 GMT 2025 , Edited by admin on Mon Mar 31 19:38:30 GMT 2025
|
PRIMARY | |||
|
5281666
Created by
admin on Mon Mar 31 19:38:30 GMT 2025 , Edited by admin on Mon Mar 31 19:38:30 GMT 2025
|
PRIMARY | |||
|
508XL61MPD
Created by
admin on Mon Mar 31 19:38:30 GMT 2025 , Edited by admin on Mon Mar 31 19:38:30 GMT 2025
|
PRIMARY | |||
|
407294
Created by
admin on Mon Mar 31 19:38:30 GMT 2025 , Edited by admin on Mon Mar 31 19:38:30 GMT 2025
|
PRIMARY | |||
|
DTXSID9034155
Created by
admin on Mon Mar 31 19:38:30 GMT 2025 , Edited by admin on Mon Mar 31 19:38:30 GMT 2025
|
PRIMARY |